medicine.washu.edu
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
#breastcancer is an active hashtag on Bluesky. In the last 30 days, 113 people shared 210 posts with it — around 7 a day. Activity is down 22% versus the previous week, peaking on Jul 17 with 14 posts.
Tags most often used together with #breastcancer.
medicine.washu.edu
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
www.youtube.com
Herceptin: A Targeted Antibody Therapy for Breast Cancer
The 2019 Lasker~DeBakey Clinical Medical Research Award honors Michael Shepard, Dennis Slamon, and Axel Ullrich for the invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer.
link.springer.com
Mapping the invisible: a Bayesian spatio-temporal analysis of male breast cancer mortality inequalities across Spanish provinces, 1999–2023 - Clinical and Translational Oncology
Background Male breast cancer (MBC) is a rare malignancy with marked geographic variation. This study presents the first nationwide spatio-temporal analysis of MBC mortality across Spain’s 52 administ...
www.ipharmacenter.com
ANVISA Updates: Breakthrough Oncology and Pediatric Approvals in Brazil | JUly 2026
Ocrelizumab Secures Expanded Approval for Pediatric Multiple SclerosisRoche has received authorization to expand the use of ocrelizumab for children and adolescents aged 12 and older with relapsing-re...
www.sciencedirect.com
The impact of expanded access to germline high penetrance genetic testing for women with a new diagnosis of invasive breast cancer or high-grade DCIS
Approximately 3% of patients with breast cancer have an inherited pathogenic variant in high-penetrance genes such as BRCA1, BRCA2 or PALB2. Knowledge…
www.bbc.co.uk
Breast cancer checks missing lots of at risk younger women, says study
Up to 95% of younger women who are at higher risk of developing breast cancer are being missed by current NHS checks, researchers warn.
open.spotify.com
Episode 215: ADC's are eating Breast Cancer. An ADC Revolution - What's next? Final Part with Dr Jay Naik Consultant Medical Oncologist
The Immunobuddies · Episode
jamanetwork.com
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer
This randomized clinical trial examines the relationship between digital patient-reported outcome monitoring with alert-based responses and fatigue in patients with metastatic breast cancer.
buff.ly
Validation, Access, and Payer Consideration for AI Diagnostics in Breast Cancer: Nancy Lin, MD | AJMC
Nancy Lin, MD, explores MMAI validation needs, turnaround advantages, equity implications, and how payers should approach AI-based diagnostics.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.